Boston Scientific
Cancer Therapies and Ablation
Boston Scientific
The Evolution of Dosimetry Using Y-90 Glass Microspheres
- 2 views
- November 24, 2020
Boston Scientific
Dosimetry Series: Multifocal Disease
FEATURING
Juan Gimenez
- 1 view
- November 24, 2020
Boston Scientific
Dosimetry Series: Radiation Segmentectomy
FEATURING
Ryan Hickey
- 1 view
- November 24, 2020
Boston Scientific
Dosimetry Series: Radiation Lobectomy
FEATURING
Robert Lewandowski
- 1 view
- November 24, 2020
Boston Scientific
LEGACY: A Multicenter Study Confirming TheraSphere™ as a Neoadjuvant or Standalone Therapy in Treating HCC
FEATURING
Vivian Bishay
- 344 views
- October 19, 2020
- 1
Boston Scientific
Evolution of the HCC Treatment: Clinical and Dosimetric Recommendations for Y-90
FEATURING
Riad Salem,
Etienne Garin
- 102 views
- September 2, 2020
Boston Scientific
Evolution of the HCC treatment: Optimized vs Standard Dosimetry
FEATURING
Etienne Garin
- 42 views
- September 9, 2020
Boston Scientific
Select Locoregional therapies as a COVID-19 Risk Mitigation treatment strategy for HCC
- 49 views
- September 2, 2020
- 1
Boston Scientific
Managing Interventional Oncology in the Time of Covid-19
- 34 views
- September 2, 2020
Boston Scientific
Long-term Outcomes of Liver Transplantation Following Y-90 Therapy as a bridge to transplant: a Multidisciplinary Approach
FEATURING
Riad Salem,
Talia Baker
- 196 views
- September 2, 2020
- 1
Boston Scientific
Cryoablation: A Tool to Expand your Renal Ablation Practice to Meet Expanding Indications
FEATURING
Andrew Gunn
- 37 views
- September 2, 2020
- 2
Boston Scientific
Safety and Efficacy of Cryoablation to Treat Pulmonary Metastatic Disease
FEATURING
Matthew Callstrom
- 135 views
- September 2, 2020
- 1
Boston Scientific
LEGACY: A Multicenter Study Confirming TheraSphere as a Neoadjuvant or Standalone Therapy in Treating HCC
Oct. 19, 2020
Faculty:
Vivian Bishay
,
Boston Scientific
- 332 views
- October 19, 2020